By Dani Kass (May 9, 2017, 7:05 PM EDT) -- A New York federal judge on Monday freed Bristol-Myers Squibb Co. and Pfizer Inc. from a consumer lawsuit accusing them of not properly warning about the risks tied to the blood-thinner Eliquis, declaring federal law would have banned the companies from changing their labels.
U.S. District Judge Denise Cote said drugmakers can only change labels if new information is discovered, which wasn't the case here. Therefore, claims stemming from stricter California laws would have been preempted by federal law, she said.
"The information contained in this literature does not constitute 'newly acquired information' under the FDA's [changes being effected] regulation," the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!